• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Prednisolone not beneficial in most cases of community-acquired pneumonia

Shiloh

Editor, Senior Moderator
Source: http://www.upi.com/Science_News/201...t-beneficial-in-pneumonia/UPI-52061267038555/

Prednisolone not beneficial in pneumonia
Published: Feb. 24, 2010 at 2:09 PM

ALKMAAR, Netherlands, Feb. 24 (UPI) -- A Netherlands-led team of scientists says it has determined prednisolone is not beneficial in most cases of community-acquired pneumonia.

The researchers, led by Dr. Dominic Snijders of the Alkmaar Medical Center, said patients with mild to moderate pneumonia should not be routinely prescribed prednisolone, a corticosteroid, because it is associated with a recurrence of symptoms after its withdrawal.

The scientists said their findings came from the first randomized double-blind clinical trial to address the subject.

"Prednisolone therapy next to antibiotic therapy in patients hospitalized with (community-acquired pneumonia) should not be recommend due to lack of clinical benefit and a higher rate of late failures," Snijders said.

The researchers' findings appear in the early online edition of the American Journal of Respiratory and Critical Care Medicine.
 
Back
Top